Protagonist Therapeutics, Inc (PTGX) Financials
Key financial figures for Protagonist Therapeutics, Inc (Q2 2026).
- Revenue
- $213M
- Net Income
- $163M
- EPS
- $2.47
- Total Assets
- $886M
- Operating Cash Flow
- $219M
Full income statement, balance sheet, and cash flow for Protagonist Therapeutics, Inc on SentiSense.